Interventional Cardiology Devices | Market Insights | Asia Pacific | 2022
Despite the negative impact of the COVID-19 pandemic in the short term, the Asia Pacific IC device market will grow modestly driven by improving healthcare infrastructure, growing demand, and increasing availability of clinical data supporting the adoption of next-generation DES, BRS, CTO-specific devices and advanced imaging techniques later in the forecast period, increasing PCI volumes, and the recent increase of the price ceiling for coronary stents in the large Chinese market will all contribute to overall expansion through 2030. However, lack of reimbursement, cost constraints, and the impact of COVID-19 pandemic will limit market growth to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Asia Pacific across a 11-year period.
